ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Adaptimmune Therapeutics Plc

Adaptimmune Therapeutics Plc is an active company incorporated on 3 December 2014 with the registered office located in Abingdon, Oxfordshire. Adaptimmune Therapeutics Plc was registered 10 years ago.
Status
Active
Active since incorporation
Company No
09338148
Public limited company
Age
10 years
Incorporated 3 December 2014
Size
Large
Turnover is over £54M
Over 250 employees
Confirmation
Submitted
Dated 18 September 2025 (1 month ago)
Next confirmation dated 18 September 2026
Due by 2 October 2026 (11 months remaining)
Last change occurred 1 month ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Group
Next accounts for period 31 December 2025
Due by 30 June 2026 (8 months remaining)
Address
60 Jubilee Avenue
Milton Park
Abingdon
Oxfordshire
OX14 4RX
England
Same address for the past 8 years
Telephone
01235430000
Email
Available in Endole App
People
Officers
11
Shareholders
1
Controllers (PSC)
-
Director • American • Lives in United States • Born in Oct 1949
Director • Chief Operating Officer • Irish • Lives in United States • Born in May 1964
Director • American • Lives in United States • Born in Jan 1972
Director • Executive, General Partner • American • Lives in United States • Born in Sep 1965
Director • British • Lives in United States • Born in May 1966
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Revitope Limited
Dr Andrew Roger Allen is a mutual person.
Active
Epitope Sciences Limited
Dr Andrew Roger Allen is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£72.79M
Decreased by £40.23M (-36%)
Turnover
£142.19M
Increased by £94.87M (+201%)
Employees
486
Increased by 47 (+11%)
Total Assets
£196.81M
Decreased by £27.86M (-12%)
Total Liabilities
-£186.39M
Decreased by £4.5M (-2%)
Net Assets
£10.41M
Decreased by £23.36M (-69%)
Debt Ratio (%)
95%
Increased by 9.74% (+11%)
Latest Activity
Mr William Charles Bertrand Appointed
21 Days Ago on 1 Oct 2025
Margaret Henry Resigned
22 Days Ago on 30 Sep 2025
Confirmation Submitted
1 Month Ago on 18 Sep 2025
Charge Satisfied
2 Months Ago on 1 Aug 2025
Charge Satisfied
2 Months Ago on 1 Aug 2025
Group Accounts Submitted
4 Months Ago on 6 Jun 2025
Confirmation Submitted
9 Months Ago on 8 Jan 2025
Group Accounts Submitted
1 Year 5 Months Ago on 20 May 2024
New Charge Registered
1 Year 5 Months Ago on 14 May 2024
New Charge Registered
1 Year 5 Months Ago on 14 May 2024
Get Credit Report
Discover Adaptimmune Therapeutics Plc's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Appointment of Mr William Charles Bertrand as a secretary on 1 October 2025
Submitted on 3 Oct 2025
Termination of appointment of Margaret Henry as a secretary on 30 September 2025
Submitted on 2 Oct 2025
Confirmation statement made on 18 September 2025 with updates
Submitted on 18 Sep 2025
Satisfaction of charge 093381480001 in full
Submitted on 1 Aug 2025
Satisfaction of charge 093381480002 in full
Submitted on 1 Aug 2025
Group of companies' accounts made up to 31 December 2024
Submitted on 6 Jun 2025
Resolutions
Submitted on 5 Jun 2025
Statement of capital following an allotment of shares on 12 May 2025
Submitted on 12 May 2025
Statement of capital following an allotment of shares on 9 May 2025
Submitted on 9 May 2025
Statement of capital following an allotment of shares on 7 May 2025
Submitted on 7 May 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year